JP Morgan Chase
ARMP icon

JP Morgan Chase’s Armata Pharmaceuticals ARMP Stock Holding History

JP Morgan Chase’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.8K Buy
+4,916
New +$45.1K ﹤0.01% 6594
2025
Q4 		– Sell
-24
Closed -$72 – 7407
2025
Q3 		$72 Hold
24
– – ﹤0.01% 7195
2025
Q2 		$46 Buy
24
+2
+9% +$3 ﹤0.01% 6902
2025
Q1 		$32 Sell
22
-3
-12% -$6 ﹤0.01% 7052
2024
Q4 		$46 Sell
25
-1
-4% -$2 ﹤0.01% 7146
2024
Q3 		$62 Sell
26
-1
-4% -$3 ﹤0.01% 7077
2024
Q2 		$74 Buy
27
+1
+4% +$3 ﹤0.01% 6949
2024
Q1 		$109 Sell
26
-79
-75% -$286 ﹤0.01% 6891
2023
Q4 		$340 Buy
+105
New +$248 ﹤0.01% 6984
2023
Q3 		– Sell
-148
Closed -$169 – 7448
2023
Q2 		$169 Buy
+148
New +$215 ﹤0.01% 6646
2020
Q4 		– Sell
-9
Closed – – 5611
2020
Q3 		$0 Hold
9
– – ﹤0.01% 5466
2020
Q2 		$0 Buy
+9
New +$31 ﹤0.01% 5354
2019
Q1 		– Sell
-64
Closed – – 5749
2018
Q4 		$0 Buy
+64
New +$312 ﹤0.01% 5674

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

JP Morgan Chase's ARMP Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Armata Pharmaceuticals (ARMP) in Q2 2026: 4,916 shares worth $31.8K. The stake represents ﹤0.01% of the portfolio and ranks #6594 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in ARMP as recently as Q3 2025.

JP Morgan Chase first reported a position in ARMP in Q4 2018 and has held it in 13 quarters since. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • JP Morgan Chase held 4,916 shares of Armata Pharmaceuticals worth $31.8K as of Q2 2026.
  • Armata Pharmaceuticals was a new JP Morgan Chase position in Q2 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6594 holding.
  • JP Morgan Chase first reported a position in Armata Pharmaceuticals in Q4 2018 and has held it in 13 quarters since.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.